PTGS2 and urinary bladder carcinoma: For bladder T24 cancer cells, osthole (50 mmol/L) could suppress the expression of COX-2, VEGF, and NF-κB, while in contrast, caspase-3 activity had been strengthened to achieve bladder cancer cell T24 inhibition [220].